BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Boonpheng B, Hansrivijit P, Thongprayoon C, Mao SA, Vaitla PK, Bathini T, Choudhury A, Kaewput W, Mao MA, Cheungpasitporn W. Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis. World J Transplant 2021; 11(7): 303-319 [PMID: 34316454 DOI: 10.5500/wjt.v11.i7.303]
URL: https://www.wjgnet.com/2220-3230/full/v11/i7/303.htm
Number Citing Articles
1
Michelle N. Rheault, Sandra Amaral, Margret Bock, Eileen Tsai Chambers, Blanche Chavers, Mireile El Ters, Rouba Garro, Rasheed Gbadegesin, Amit Govil, Lyndsay Harshman, Hatem Amer, David K. Hooper, Ajay K. Israni, Samy Riad, Junichiro Sageshima, Ron Shapiro, Michael Seifert, Jodi Smith, Randall Sung, Christie P. Thomas, Qi Wang, Priya S. Verghese. A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study designFrontiers in Nephrology 2023; 3 doi: 10.3389/fneph.2023.1181076
2
Simon R. Knight. Transplant Trial WatchTransplant International 2023; 36 doi: 10.3389/ti.2023.11816
3
Andrea Angeletti, Maurizio Bruschi, Xhuliana Kajana, Edoardo La Porta, Sonia Spinelli, Gianluca Caridi, Francesca Lugani, Enrico Eugenio Verrina, Gian Marco Ghiggeri. Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatmentFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1213203
4
Syeda Behjat Ahmad, Yonatan Peleg, Wooin Ahn. Current approaches to overcome recurrent focal segmental glomerulosclerosis after kidney transplantationCurrent Opinion in Nephrology & Hypertension 2024; 33(1): 61 doi: 10.1097/MNH.0000000000000946
5
Byung Hwa Park, Ye Na Kim, Ho Sik Shin. New treatment for antibody-mediated rejection: interleukin-6 inhibitorsClinical Transplantation and Research 2024; 38(1): 1 doi: 10.4285/ctr.23.0069
6
Kamila Szumilas, Aleksandra Wilk, Piotr Wiśniewski, Anna Gimpel, Violetta Dziedziejko, Markus Kipp, Andrzej Pawlik. Current Status Regarding Immunosuppressive Treatment in Patients after Renal TransplantationInternational Journal of Molecular Sciences 2023; 24(12): 10301 doi: 10.3390/ijms241210301
7
Liuwei Wang, Lu Yu, Yulin Wang, Yanhong Guo, Zihan Zhai, Lin Tang. Rituximab treatment of adults with primary focal segmental glomerulosclerosisScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-33678-y
8
Rupesh Raina, Swathi Jothi, Dieter Haffner, Michael Somers, Guido Filler, Prabhav Vasistha, Ronith Chakraborty, Ron Shapiro, Parmjeet S. Randhawa, Rulan Parekh, Christopher Licht, Timothy Bunchman, Sidharth Sethi, Guneive Mangat, Joshua Zaritsky, Franz Schaefer, Bradley Warady, Sharon Bartosh, Mignon McCulloch, Khalid Alhasan, Agnieszka Swiatecka-Urban, William E. Smoyer, Anil Chandraker, Hui Kim Yap, Vivekanand Jha, Arvind Bagga, Jai Radhakrishnan. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statementsKidney International 2024; 105(3): 450 doi: 10.1016/j.kint.2023.10.017
9
Hye Eun Kwon, Young Hoon Kim, Sang Ah Lee, Jae Jun Lee, Youngmin Ko, Sung Shin, Joo Hee Jung, Frances S. Sung, Chung Hee Baek, Hyosang Kim, Su-Kil Park, Hyunwook Kwon. Post-operative recurrence of focal segmental glomerulosclerosis according to pre-transplant treatment after kidney transplantationBMC Nephrology 2023; 24(1) doi: 10.1186/s12882-023-03098-1
10
Laura Connelly‐Smith, Caroline R. Alquist, Nicole A. Aqui, Jan C. Hofmann, Reinhard Klingel, Oluwatoyosi A. Onwuemene, Christopher J. Patriquin, Huy P. Pham, Amber P. Sanchez, Jennifer Schneiderman, Volker Witt, Nicole D. Zantek, Nancy M. Dunbar. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special IssueJournal of Clinical Apheresis 2023; 38(2): 77 doi: 10.1002/jca.22043